Factor Therapeutics Share Price and Company Fundamentals



Price
$0.005
Change
0.000 (0.000%)
52 week
0.002 - 0.007

Last traded: 07/15/2020

Factor Therapeutics Limited operates as a biotechnology company that focuses on developing and commercializing advanced wound care therapies. The company was formerly known as Tissue Therapies Limited and changed its name to Factor Therapeutics Limited in May 2016. Factor Therapeutics Limited was incorporated in 2002 and is based in Brisbane, Australia.

Key Metrics

PE ratio

PB ratio

1.67

Dividend yield

Beta

0.55

Market cap

$5.21M

Enterprise value

$2.01M

Company profile

Primary activitiesBiotechnology Research and Development
Industry / SectorBiotechnology / Healthcare
Websitehttp://www.factor-therapeutics.com
Mailing address10 Eagle Street Level 21 Brisbane QLD 4000 Australia
Phone / Fax61 7 3334 3900 /
Share registryLINK MARKET SERVICES LIMITED

Dividends

Factor Therapeutics does not pay dividends.

Company Executives

As of May 2021, following are the company executives and directors listed on Factor Therapeutics.

NameTitleAgeTotal Pay
Ms. Melanie Farris M.A.I.C.D., ACIS) BComn, (AGIA, GradDip, ACGNon-Exec. Director & Company Sec.

Profitability and management effectiveness

Profit margin

42.24%

Operating margin

44.43%

Return on assets

5.80%

Return on equity

9.31%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Factor Therapeutics is 5.21M and its enterprise value is 2.01M. The enterprise value to revenue ratio of FTT is 3.02.

The FTT's stocks Beta value is 0.55 making it 45% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Factor Therapeutics (FTT)

Factor Therapeutics (ASX:FTT) Frequently Asked Questions

1. What is Factor Therapeutics's Stock Symbol?

Factor Therapeutics trades on ASX under the ticker symbol "FTT".

2. What is Factor Therapeutics's stock price today?

One share of FTT stock can currently be purchased for approximately $0.005.

3. How can I contact Factor Therapeutics?

Factor Therapeutics's mailing address is 10 Eagle Street Level 21 Brisbane QLD 4000 Australia. The company can be reached via phone at 61 7 3334 3900.

4. What is Factor Therapeutics's official website?

The official website of Factor Therapeutics is http://www.factor-therapeutics.com.

5. Which share registry manages Factor Therapeutics's stock?

Factor Therapeutics's stock is managed by LINK MARKET SERVICES LIMITED.